Adimmune

Products

AdimFlu-S(QIS)

AdimFlu-S (QIS)

Quadrivalent influenza vaccine

安定伏裂解型流感疫苗(A/H1N1)

Product Description: 

AdimFlu-S(QIS) is a vaccine to protect adults and children older than 3 years from flu (influenza).When you are given the vaccine your body's immune system makes antibodies to protect you against the types of flu virus that are in the vaccine.

The vaccine does not contain any live virus particles, so it cannot give you the flu.

After receiving the vaccine, the immune system will make enough antibody to protect the body against the types of virus (H1N1, H3N2, B type Yamagata lineage, B type Victoria lineage ) that are in the vaccine in two to three weeks. This protection against flu should last for 6–12 months.

This vaccine has been designed for this winter season, and can only help to protect you against

the types of flu virus that have been used to make the vaccine.

Influenza Vaccine is manufactured by culturing virus in embryonated eggs, and then purifying, splitting, and inactivating it.

The composition of the vaccine complies with the recommendation of the WHO for this winter, including 4 virus strains.

Tetanus Toxoid Alum Precipitated

Tetanus Toxoid Alum Precipitated

A Method of use:Number of product-license Taiwan:DOH-BM000113

Tetanus Toxoid Alum Precipitated

Product Description: 

Tetanus toxoid comes from Clostridium tetani, Harvard strain AT-47. it is a sterilized suspension obtained after virus attenuation by formaldehyed treatment and adsorption with aluminum phosphate. At present, this preparation is only used for prevention of tetanus after injury.

JAPANESE ENCEPHALITIS VACCINE

JAPANESE ENCEPHALITIS VACCINE

A Method of use:Number of product-license Taiwan:DOH-BM000082

JAPANESE ENCEPHALITIS VACCINE

Product Description: 

Japanese Encephalitis Vaccine is produced using mouse brain. The virus is extracted from mouse brain tissue and subjected to inactivation by formailin. Purification by ultracentrifugation and treatment with Protamin Sulfate reduces the mouse protein content in the vaccine, thus lowering the occurrence of post-vaccination encephalitis.